Executive Director, Nonclinical and Bioanalytical Development
Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.
Biopharmaceutical leader with over 20 years of academic and industry experience in biomedical research and drug development. Scientific design and management of drug discovery, IND-enabling preclinical, BLA-enabling bioanalytic, and post-market pharmacovigilance programs with mostly large molecule immunomodulatory drugs for oncology and autoimmunity. Operational and scientific leadership of laboratories supporting research, GLP, CGMP, GCP, and CLIA studies. Leader of international expansion for global laboratory capabilities including US, Canada, Europe, China, Japan, India and Australia. Full member of the Society of Toxicology (SOT) and the American College of Toxicology (ACT).
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Shelley Sims Belouski Phd at Xencor then you’ve come to the right place.
Wondering if it's shelley@xencor.com, shelley.phd@xencor.com, phd@xencor.com, or sphd@xencor.com? We have the answers for you.